Hims & Hers Health Inc
NYSE:HIMS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (31.6), the stock would be worth $39.4 (29% upside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 24.5 | $30.56 |
0%
|
| 3-Year Average | 31.6 | $39.4 |
+29%
|
| 5-Year Average | 21.8 | $27.23 |
-11%
|
| Industry Average | 18.7 | $23.3 |
-24%
|
| Country Average | 16.7 | $20.81 |
-32%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Hims & Hers Health Inc
NYSE:HIMS
|
6.9B USD | 24.5 | 54.1 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.1B USD | 14 | 56 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.7B EUR | 10.7 | 13.5 | |
| US |
|
Cigna Corp
NYSE:CI
|
72.6B USD | 0 | 12.2 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 11.1 | 23.6 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
22.7B EUR | 12.3 | 17.9 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.8B USD | 14.4 | 21.4 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 15.9 | 24.7 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 6.5 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.6B USD | -65.6 | -27.9 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 10.4 | 13.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 11.7 |
| Median | 16.7 |
| 70th Percentile | 23.6 |
| Max | 3 178 983.5 |
Other Multiples
Hims & Hers Health Inc
Glance View
Once upon a time in the bustling landscape of telehealth services, Hims & Hers Health Inc. emerged as a pioneering force, reshaping the narrative around personal wellness and healthcare accessibility. Founded with a direct-to-consumer approach, the company cleverly positioned itself at the intersection of convenience and necessity. Operating primarily through an online platform, Hims & Hers offers a range of health-related products and services targeting conditions often stigmatized or considered sensitive, such as hair loss, erectile dysfunction, skincare, mental health, and more. The company’s business model hinges on its ability to bypass traditional healthcare barriers, providing easy access to licensed healthcare professionals and personalized treatment plans through a seamless internet-based interface. Their revenue model is multifaceted, but at its core are product sales and subscription services. Customers begin their journey by completing a brief online consultation, which, in many states, can involve a healthcare professional reviewing their information without an in-person visit. Once approved, the company's network of telehealth providers prescribes medications, which are conveniently delivered to customers’ doorsteps. Whether purchasing single products or opting for monthly subscriptions, users are drawn to the discretion and accessibility of the service. Hims & Hers markets its offerings directly through savvy digital campaigns, leveraging the power of modern e-commerce to reach younger demographics who appreciate privacy and efficiency in managing their health. Thus, the company stands as a compelling example of how technology can democratize healthcare, wrapped seamlessly within the bounds of consumer-friendly digital infrastructure.